Chantelle Hartle
Appearances
Global News Podcast
Starmer warns US backstop needed for Ukraine peace deal
The current standard PSA test for prostate cancer measures only the amount of a particular protein, prostate-specific antigen, in a man's blood. But it has a low accuracy rate of around 45%. Some men who have a positive PSA result are required to have invasive scans, only to later discover that they don't have cancer.
Global News Podcast
Starmer warns US backstop needed for Ukraine peace deal
By contrast, scientists in Cambridge claim this latest test, which requires a blood and urine sample, has between 96 and 99 percent accuracy. It measures not only prostate-specific antigen, but analyzes 100 other data points for specific genes and proteins that have been shown to increase the risk of prostate cancer.
Global News Podcast
Starmer warns US backstop needed for Ukraine peace deal
Professor Chris Evans, the chief scientific officer of EDX Medical, which has developed the test, said it was truly game-changing.
Global News Podcast
Starmer warns US backstop needed for Ukraine peace deal
The findings by the team in Cambridge have not yet been peer-reviewed. Scientists will now focus on collecting more data before seeking approval from medical regulators. But confidence is high. The team expect to launch this test in the UK later this year or early in 2026.
Global News Podcast
Starmer warns US backstop needed for Ukraine peace deal
If approved, they say it would revolutionise prostate cancer screening for men aged 45 to 70, adding that it would first be available to private patients.